Page last updated: 2024-10-17

2,3-diaminopropionic acid and Diabetic Nephropathies

2,3-diaminopropionic acid has been researched along with Diabetic Nephropathies in 1 studies

3-aminoalanine : A diamino acid that is alanine in which one of the hydrogens of the methyl group is replaced by an amino group.

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J1
Qiu, P1
Wang, S1
Wu, J1
He, Q1
Li, K1
Xu, L1

Other Studies

1 other study available for 2,3-diaminopropionic acid and Diabetic Nephropathies

ArticleYear
β-N-Oxalyl-L-α,β-diaminopropionic acid from Panax notoginseng plays a major role in the treatment of type 2 diabetic nephropathy.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 114

    Topics: Amino Acids, Diamino; Animals; beta-Alanine; Cell Line; Cell Proliferation; Diabetes Mellitus, Exper

2019